SCHEMBL15908121

SCHEMBL15908121

CCOCCOCC(=O)Oc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
CYP19A1 P11511 1/20 0.42
GLA P06280 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
MAPT P10636 1/20 0.42
GAA P10253 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3818237 0.91 ELANE (0.50) ELANEALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL3438961 0.91 CYP19A1 (0.49) ELANEALDH1A1KDM4EHSD17B10CYP19A1
SCHEMBL3438962 0.89 CYP19A1 (0.47) ELANEALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL11956765 0.88 ELANE (0.45) ELANEALDH1A1KDM4EHSD17B10CYP19A1
SCHEMBL16326823 0.86 ALDH1A1 (0.46) ELANEALDH1A1KDM4EHSD17B10CYP19A1
SCHEMBL14707361 0.86 ELANE (0.46) ELANEALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL5318627 0.84 SMN1; SMN2 (0.49) ELANEALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL11437247 0.83 CYP19A1 (0.52) ELANEALDH1A1KDM4EHSD17B10CYP19A1
SCHEMBL8584306 0.83 ALDH1A1 (0.46) ELANEALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL29197615 0.83 ALDH1A1 (0.46) ELANEALDH1A1KDM4EHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140213688-A1 Absorbable Multi-Putty Bone Cements and Hemostatic Compositions and Methods of Use ABYRX, INC. (US) 2014-07-31 US disclosed